Evidera
Eric Stovall has a diverse work experience in the clinical research and business systems field. Eric started their career in 2005 at PPD as a Project Assistant, providing administrative support and tracking study data. Eric then moved on to become a Clinical Research Specialist. In 2007, Eric joined Triumph Consultancy Services as a Consultant, where they focused on system specifications, project management, and change management activities. Eric later returned to PPD in 2013, taking on roles as Senior Business Systems Analyst and Senior Manager Site Payments. In 2020, they joined Evidera as an Associate Director of PPAS Technology Solutions.
Eric Stovall obtained a Bachelor of Arts (B.A.) degree in Health and Physical Education/Fitness from the University of North Carolina Wilmington. Eric attended the university from 2001 to 2004.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.